Bringing Structure to Substance Information

Posted 28 August 2015 By Niels Henriksen

placeholder+image This article discusses compliance challenges  pharmaceutical companies face with the International Organization for Standardization (ISO) Identification of Medicinal Products (IDMP) standard for structured  substance information.

Share this article:

Categories: Active pharmaceutical ingredients, Postmarket surveillance, Articles, Features, ISO, APIs

Tags: pharmaceuticals, pharmacovigilance, International Organization for Standardization, ISO, Identification of Medicinal Products, IDMP

Regulatory Exchange: Latest Updates From the Community